• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

52.39 +1.51 (+2.97%)
Official Closing Price Updated: 7:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,138,559
Open 51.61
Bid (Size) 52.48 (200)
Ask (Size) 52.50 (200)
Prev. Close 50.88
Today's Range 51.41 - 52.41
52wk Range 43.08 - 93.80
Shares Outstanding N/A
Dividend Yield 4.20%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
2 Tailwinds Behind Novo Nordisk Stock Heading Into 2026 ↗
January 03, 2026
The pharmaceutical leader looks poised to stop the bleeding. 
Via The Motley Fool
News headline image
The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls
January 02, 2026
Yesterday marked the official commencement of the first-ever "Maximum Fair Prices" (MFPs) for ten of the most widely used drugs in the Medicare program, a direct result of the Inflation Reduction Act’s... 
Via MarketMinute
Topics Economy Intellectual Property World Trade

Performance

YTD
N/A
N/A
1 Month
+9.2%
+9.2%
3 Month
-12.2%
-12.2%
6 Month
-24.4%
-24.4%
1 Year
-40.2%
-40.2%

More News

Read More
News headline image
The GLP-1 Pricing Revolution: How Novo Nordisk and Eli Lilly Redefined the Weight-Loss Market for 2026
January 02, 2026
Via MarketMinute
Topics Economy Intellectual Property
News headline image
Pfizer’s Dividend Trap or Deep Value? Analyzing the Pharma Giant as Shares Languish Below $30
January 01, 2026
Via MarketMinute
Topics Intellectual Property
News headline image
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
January 01, 2026
Via PredictStreet
Topics Economy Lawsuit World Trade
News headline image
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
December 31, 2025
Via MarketMinute
Topics Economy Intellectual Property Law Enforcement
News headline image
FDA Approves Novo Nordisk's Wegovy Pill: A Game Changer for 2026 ↗
December 31, 2025
Via MarketBeat
News headline image
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Why Novo Nordisk Stock Dropped on Monday ↗
December 30, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Rhythm Pharmaceuticals Faces Gravity: FDA Delays and Valuation Pressures Cool 2025’s Biotech Darling
December 30, 2025
Via MarketMinute
Topics ETFs Economy World Trade
News headline image
The 2026 Horizon: Wall Street Bets on the 'Application Era' and the Nuclear Renaissance
December 29, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
December 29, 2025
Via MarketMinute
Topics ETFs Intellectual Property
News headline image
The Trillion-Dollar Apothecary: Inside Eli Lilly’s Era of Metabolic Dominance
December 29, 2025
Via PredictStreet
Topics Earnings Economy Intellectual Property
News headline image
Market Breather: Benchmarks Pause Record-Breaking Year as Volatility Signals Year-End Reset
December 29, 2025
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
This Beaten-Down Stock Just Jumped By 8%. Time to Buy? ↗
December 29, 2025
Via The Motley Fool
News headline image
Novo Nordisk Slashes Weight Loss Drug Price By Up To 50% In China: Report ↗
December 29, 2025
Via Stocktwits
Topics Intellectual Property
News headline image
The Weight Loss Drug Competition Is Heating Up: These 2 Industry Leaders Just Filed Competing Drugs with the FDA. ↗
December 29, 2025
Via The Motley Fool
News headline image
3 Drug Stocks to Buy at a Discount ↗
December 27, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Should You Invest in Ozempic Maker Novo Nordisk in 2026? ↗
December 26, 2025
Via The Motley Fool
News headline image
Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026 ↗
December 26, 2025
Via MarketBeat
News headline image
This Smallcap Pharma Stock Is Gaining Retail Buzz Ahead Of A Key FDA Ruling ↗
December 26, 2025
Via Stocktwits
News headline image
Buying This Pharmaceutical Stock Could Make You a Millionaire Retiree ↗
December 26, 2025
Via The Motley Fool
News headline image
Betting on the 'Santa Squeeze': Unusual Options Activity Surges as 2025 Draws to a Close
December 25, 2025
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle? ↗
December 25, 2025
Via The Motley Fool
News headline image
Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
December 25, 2025
Via MarketMinute
Topics Economy Intellectual Property

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 52.39
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 01/02/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap